Earnings Call Summary | Precision Optics(POCI.US) Q3 2024 Earnings Conference
Earnings Call Summary | Precision Optics(POCI.US) Q3 2024 Earnings Conference
The following is a summary of the Precision Optics Corporation, Inc. (POCI) Q3 2024 Earnings Call Transcript:
以下是Precision Optics Corporation，Inc.（POCI）2024財年第三季度業績會議通話記錄摘要：
Financial Performance:
金融業績：
Precision Optics reported Q3 revenue of $5.24 million, a significant increase driven by new production orders and record engineering revenue.
Gross margins continued to improve, leading to a positive adjusted EBITDA of $52,000.
Company lowered its operating loss from $493,000 in Q3 fiscal 2023 to $258,000 in Q3 fiscal 2024 due to higher gross profit and reduced operating expenses.
Net loss dropped to $317,000 in Q3, a decrease from the previous year's $398,000.
Company projected similar or higher revenue for Q4 fiscal 2024, with improved margins leading to enhanced profitability.
Precision Optics報告了第三季度營業額爲524萬美元，這是由於新的生產訂單和創紀錄的工程收入推動的顯着增長。
毛利率繼續提高，帶來了52000美元的正調整EBITDA。
由於更高的毛利潤和降低的營業費用，公司將其第三財季的運營虧損從2023財年第三季度的493,000美元降至2024財年第三季度的258,000美元。
淨虧損降至第三季度的317,000美元，低於去年的398,000美元。
公司預計2024財年第四季度的營業收入相似或更高，其提高的毛利率將導致增強的盈利能力。
Business Progress:
業務進展：
A record single-use endoscope assembly order for cystoscopy surgery denotes a significant business achievement.
New order is anticipated to yield $2.2 million and $4.6 million in revenues in fiscal 2025 and 2026 respectively.
Company increased focus in the aerospace and defense market, evident from two follow-on production orders.
Explorations of expansion opportunities are underway in both defense aerospace and medical device markets.
Consolidation of duplicate production locations and management groups is set to improve profitability.
Plans to continue growth in fiscal 2025 by leveraging their broad technical capabilities and resources.
Lingering uncertainties depend on speed new programs reach higher volumes, but company expects Q4 revenue to either mirror or surpass Q3's.
Acquisition of Lighthouse has fostered stronger connections with larger clients.
Three substantial new programs, past the prototype phase, are expected to enter production within six months, two of which are awaiting 510(k) approval.
針對膀胱鏡手術的一次記錄性一次性內窺鏡組件訂購代表了重要的業務成就。
預計新訂單將在2025財年和2026財年分別產生220萬美元和460萬美元的收入。
公司加強了對航空航天與國防市場的關注，從兩份跟進生產訂單可見。
正在開展在國防航空和器械市場擴展機會的探索。
合併重複的生產地點和管理團隊，以提高盈利能力。
利用他們廣泛的技術能力和資源，計劃在2025財年繼續增長。
新項目達到更高的量級的速度仍存在不確定性，但是公司預計第四季度的收益將與第三季度相同或更高。
收購Lighthouse促進了與較大客戶更強的聯繫。
預計有三個重大的新項目將跨越原型階段，六個月內進入生產階段，其中兩個正等待510(k)批准。
More details: Precision Optics IR
更多詳情：Precision Optics IR
Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.
提示：如需更全面的詳情，請參閱投資人關係網站。本文僅供投資者參考，不作任何指引或建議。
譯文內容由第三人軟體翻譯。